Cargando…

2781. The Use of Aminoglycosides for Treatment of Urinary Tract Infections in Pediatric Patients, a Carbapenem-Sparing Approach

BACKGROUND: Urinary tract infections (UTIs) caused by antimicrobial-resistant pathogens have been increasingly reported. Aminoglycosides are known to be effective therapy for UTIs, however their use is not common due to a fear of nephrotoxicity. Overuse of broad-spectrum antimicrobial agents, partic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Legaspi, Jamie, Mongkolrattanothai, Kanokporn, Edward, Priya, Orbach, Regina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678181/ http://dx.doi.org/10.1093/ofid/ofad500.2392

Ejemplares similares

477. Characterization of Extended-Spectrum Β-Lactamase (ESBL) Producing Gram-negative (GN) Urinary Tract Infections (UTI) in Pediatric Patients
por: Stach, Leslie, et al.
Publicado: (2019)

519. Multidrug-resistant Gram-Negative Bacteremia in Pediatric Patients: Is It Time to Change to Empiric Meropenem?
por: Mongkolrattanothai, Kanokporn, et al.
Publicado: (2019)

2122. Isavuconazonium for Invasive Fungal Therapy: Single-Center Pediatric Experience
por: Mongkolrattanothai, Kanokporn, et al.
Publicado: (2019)

276. Vancomycin Utilization in a Neonatal Intensive Care Unit
por: Mongkolrattanothai, Kanokporn, et al.
Publicado: (2018)

2781. Statistical Modeling to Predict Maternal RSV Vaccine Efficacy from Neutralizing Titers
por: Cai, Bing, et al.
Publicado: (2019)

1354. Reducing vancomycin utilization rate in a level 4 NICU
por: Chang, Millie R, et al.
Publicado: (2020)

Aminoglycoside Susceptibility Agreement between an Automated System and Broth Microdilution for Carbapenem-resistant Enterobacteriaceae
por: Kulengowski, Brandon, et al.
Publicado: (2017)

Carbapenem-Resistant but Cephalosporin-Susceptible Pseudomonas aeruginosa in Urinary Tract Infections: Opportunity for Colistin Sparing
por: Gajdács, Márió
Publicado: (2020)

Acute Flaccid Myelitis Cases Presenting During a Spike in Respiratory Enterovirus D68 Circulation: Case Series From a Single Pediatric Referral Center.
por: Naccache, Samia, et al.
Publicado: (2017)

2246. A comparison between empiric carbapenem and non-carbapenem use for patients admitted with urinary tract infections and sepsis in the Dominican Republic
por: De Luna, David, et al.
Publicado: (2023)

1452. Is Carbapenem-Sparing Therapy as Effective as Carbapenems Against Extended-Spectrum β-Lactamase Producing Enterobacteriaceae in UTI?
por: Hyun, Jonghoon, et al.
Publicado: (2019)

508. Gentamicin Non-susceptibility is Associated with Persistence of Carbapenem-Resistant Klebsiella pneumoniae in the Urinary Tract
por: Luterbach, Courtney, et al.
Publicado: (2019)

The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC): A report of 2,781 cases in a Chinese population
por: Zhu, Yanli, et al.
Publicado: (2020)

In Vivo Efficacy of Cefiderocol against Carbapenem-Resistant Gram-Negative Bacilli in Murine Urinary Tract Infection Models
por: Matsumoto, Shuhei, et al.
Publicado: (2017)

2801. Antimicrobial Spectrum of Plazomicin and Other Aminoglycosides against Multidrug-Resistant and Carbapenem-Resistant Enterobacterales When Applying New Breakpoints
por: Sader, Helio S, et al.
Publicado: (2023)

1153. ESBL Producing E. coli Urinary Tract Infections in Children: Is Carbapenem Always Necessary?
por: del Carmen, Ruiz Cabrales Diva, et al.
Publicado: (2021)

2261. Oral Fosfomycin for Treatment of Urinary Tract Infections Due to Extended-Spectrum β-Lactamase and Carbapenem-Resistant Enterobacteriaceae
por: Hefler, Jade L, et al.
Publicado: (2019)

Epidemiology of community-onset Staphylococcus aureus infections in pediatric patients: an experience at a Children's Hospital in central Illinois
por: Mongkolrattanothai, Kanokporn, et al.
Publicado: (2009)

85. The Impact of Carbapenem-Sparing Interventions on the Evolution of Resistance in Pseudomonas aeruginosa in the USA
por: Townsend, Jeffrey, et al.
Publicado: (2020)

2540. Can aminoglycoside dosing be improved through use of pharmacokinetic models from other aminoglycosides?
por: Faldasz, Jonathan, et al.
Publicado: (2023)

2430. Impact of USCAST Proposed Breakpoint Changes to Aminoglycosides, Cyclines, and Levofloxacin on Carbapenem-Resistant Enterobacteriaceae at a US Tertiary Referral Academic Medical Center
por: Kulengowski, Brandon, et al.
Publicado: (2018)

1472. Non-Carbapenems for Treating Community-Associated Urinary Tract Infection Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Children
por: Joo Jung, Hyun, et al.
Publicado: (2019)

Antibiotic Prescription Practice for Pediatric Urinary Tract Infection in a Tertiary Center
por: Alghounaim, Mohammad, et al.
Publicado: (2017)

1458. Burden of Illness in Patients with Urinary Tract Infections With or Without Bacteremia Caused by Carbapenem-Resistant Gram-Negative Pathogens in US Hospitals (2014 to 2018)
por: Shields, Ryan K, et al.
Publicado: (2019)

1483. Comparison of Outcomes in Urinary Tract Infections Caused by SPICE Organisms Treated with Non-Carbapenem-β-lactams vs. Non-β-lactams Agents
por: Sapozhnikov, Julia, et al.
Publicado: (2019)

Impact of FilmArray™ Respiratory Panel testing on the clinical management of pediatric bone marrow transplant patients
por: Precit, Mimi R., et al.
Publicado: (2021)

285. The Pediatric Urinary Microbiome: A Comparison of infants under 12 months with and without Urinary Tract Infection in South Korea
por: Hyen Lee, Ji, et al.
Publicado: (2023)

2542. Attenuation of Polymyxin and Aminoglycoside-Associated Nephrotoxicity
por: Hudson, Cole, et al.
Publicado: (2023)

Urinary Tract Trauma in Children
Publicado: (2016)

1257. Re-Evaluation of Cefepime or Piperacillin-Tazobactam to Decrease Use of Carbapenems in ESBL-Producing Enterobacterales Urinary Tract Infections (REDUCE-UTI)
por: Branton, Alexander C, et al.
Publicado: (2021)

Evaluation of automated systems for aminoglycosides and fluoroquinolones susceptibility testing for Carbapenem-resistant Enterobacteriaceae
por: Zhao, Zhichang, et al.
Publicado: (2017)

Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems
por: Karakonstantis, Stamatis, et al.
Publicado: (2020)

A Multidisciplinary Team Approach to Reducing Catheter-associated Urinary Tract Infections in Pediatric Intensive Care
por: McClusky, Jessica L., et al.
Publicado: (2019)

Epidemiology, Microbiology and Outcomes of Catheter-Associated Urinary Tract Infection and Complicated Urinary Tract Infection in the USA
por: Merchant, Sanjay, et al.
Publicado: (2017)

1506. Association of Antibiotic Treatment Duration with First Recurrence of Uncomplicated Urinary Tract Infection in Pediatric Patients
por: Afolabi, Titilola M, et al.
Publicado: (2018)

500. Prevalence of Extended-Spectrum β-lactamase and Carbapenem-Resistant Gram-Negative Bacteria in Patients with Urinary Tract Infection and Urosepsis Admitted through Emergency Departments in the United States
por: Takhar, Sukhjit, et al.
Publicado: (2019)

Urinary tract infection
por: La Scola, Claudio
Publicado: (2014)

Bacillus Coli Infections of the Urinary Tract
Publicado: (1912)

In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii
por: Juhas, Mario, et al.
Publicado: (2019)

Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas aeruginosa
por: Kosai, Kosuke, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t7u7p00rq9or7p4itafng2fdnt